Appeal No. 2004-0902 Page 8 Application No. 09/780,060 arrays (including but not limited to lamellar liquid crystals) that do undergo a phase transition to a crystalline lamellar phase.” Id. (emphasis in original). The above arguments are also not found to be convincing, as Kawada does not look at the ability of the compositions taught by that reference to crystallize when applied to mammalian skin. As noted above, the specification specifically teaches that [a]pplication to the skin results in a rapid series of changes to the composition, all or some of which are responsible for inducing the phase transition of the lamellar arrangement. These changes include pH change, drying, packing and pressure changes, ionic strength change, temperature change; fusion of liposomes in close proximity; all of these changes may influence hydration state of the composition. All or some of these changes drive conversion from the non-crystalline phase to the crystalline phase. Specification, page 9. The above passage demonstrates that it is application to mammalian skin that drives the phase change of the composition, and the teachings of Kawada demonstrating that their liquid crystals do not crystallize when heated and cooled in a sealable silver pan do not address the issue of whether the reference’s compositions would adopt a crystalline lamellar phase when applied to mammalian skin. With respect to claims 6, 7 and 15, appellants argue that Kawada does not teach that liposomes form, or that “lipid particles of any particular type or size form.” Appeal Brief, page 6. Appellants assert that “[t]he secondary reference teaches the formation of multilamellar liposomes of the asserted size range by shaking a mixture of phosphatidyl choline (egg lecithin), cholesterol and an acidPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 NextLast modified: November 3, 2007